Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Sheinfeld

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancerAndrew J Stephenson, George J Bosl, Robert J Motzer, et al.
The Journal of Urology|June 7, 2006
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissectionBrett S Carver, Fernando J Bianco, Bobby Shayegan, et al.
Cancer|January 4, 2008
The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumorAtreya Dash, Brett S Carver, Jason Stasi, et al.
Urology|December 14, 2024
The Outcomes of Onco-Testis Sperm Extraction at the Time of Radical OrchiectomyJose M Flores, Ignacio Henriquez, Joshua S Jue, et al.
The Journal of Urology|September 6, 2023
Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the RetroperitoneumRichard S Matulewicz, Nicole Benfante, Samuel A Funt, et al.
AJR. American Journal of Roentgenology|January 24, 2003
Is there an increased incidence of contralateral testicular cancer in patients with intratesticular microlithiasis?Ariadne M Bach, Lucy E Hann, Weiji Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Alessia Donadio, et al.
Urology|March 27, 2012
Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease siteTimothy A Masterson, Brett S Carver, Bobby Shayegan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcomeAndrew J Stephenson, George J Bosl, Robert J Motzer, et al.
Urology|December 17, 2011
Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissectionR Houston Thompson, Brett S Carver, George J Bosl, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancerAndrew J Stephenson, George J Bosl, Robert J Motzer, et al.
The Journal of Urology|June 7, 2006
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissectionBrett S Carver, Fernando J Bianco, Bobby Shayegan, et al.
Cancer|January 4, 2008
The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumorAtreya Dash, Brett S Carver, Jason Stasi, et al.
Urology|December 14, 2024
The Outcomes of Onco-Testis Sperm Extraction at the Time of Radical OrchiectomyJose M Flores, Ignacio Henriquez, Joshua S Jue, et al.
The Journal of Urology|September 6, 2023
Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the RetroperitoneumRichard S Matulewicz, Nicole Benfante, Samuel A Funt, et al.
AJR. American Journal of Roentgenology|January 24, 2003
Is there an increased incidence of contralateral testicular cancer in patients with intratesticular microlithiasis?Ariadne M Bach, Lucy E Hann, Weiji Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Alessia Donadio, et al.
Urology|March 27, 2012
Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease siteTimothy A Masterson, Brett S Carver, Bobby Shayegan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcomeAndrew J Stephenson, George J Bosl, Robert J Motzer, et al.
Urology|December 17, 2011
Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissectionR Houston Thompson, Brett S Carver, George J Bosl, et al.
Pageof 12